Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran

بواسطة Leung, Timothy S, Law, Ernest H
الحاوية / القاعدة Drug Des Devel Ther (2015)

Dabigatran in atrial fibrillation: New kid on the block

بواسطة Leung, Timothy S., Fradette, Miriam, Thompson, Ann, Koshman, Sheri L.
منشور في 2012